Citations

Showing 10 of 108162 citations.

Smooth muscle differentiation shapes domain branches during mouse lung development
Goodwin, Katharine , Guyomar, Tristan , Miller, Erin , Košmrlj, Andrej , Nelson, Celeste M. , Radisky, Derek C. , Nelson, Celeste M , Mao, Sheng

Mayo Clinic

Development | October 23, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1242/dev.181172 | PMID 31645357 Get It

During branching morphogenesis, a simple cluster of cells proliferates and branches to generate an arborized network that facilitates fluid flow. The overall architecture of the mouse lung is established by domain branching, wherein new branches form laterally off the side of an existing branch. The airway epithelium develops concomitantly with a layer of smooth muscle that is derived from the embryonic mesenchyme. Here, we examined the role of smooth muscle differentiation in shaping emerging domain branches. We found that the position and morphology of domain branches are highly stereotyped, as is the pattern of smooth muscle that differentiates around the base of each branch. Perturbing the pattern of smooth muscle differentiation genetically or pharmacologically causes abnormal domain branching. Loss of smooth muscle results in ectopic branching and decreases branch stereotypy. Increased smooth muscle suppresses branch initiation and extension. Computational modeling revealed that epithelial proliferation is insufficient to generate domain branches and that smooth muscle wrapping is required to shape the epithelium into a branch. Our work sheds light on the physical mechanisms of branching morphogenesis in the mouse lung.
Multi-frequency Electrocochleography Measurements can be Used to Monitor and Optimize Electrode Placement During Cochlear Implant Surgery
Saoji, Aniket A. , Patel, Neil S. , Carlson, Matthew L. , Neff, Brian A., Koka, Kanthaiah , Tarigoppula, Venkata S Aditya , Driscoll, Colin L. W.

Mayo Clinic

Otology & Neurotology | October 23, 2019 | Volume: 40 | Issue: 10 | Pages: 1287-1291

10.1097/mao.0000000000002406 | PMID 31644474 Get It

Objective: To report the use of multi-frequency intra-cochlear electrocochleography (ECOG) in monitoring and optimizing electrode placement during cochlear implant surgery. An acoustic pure tone complex comprising of 250, 500, 1000, and 2000 Hz was used to elicit ECOG, or more specifically cochlear microphonics (CMs), responses from various locations in the cochlea. The most apical cochlear implant electrode was used as the recording electrode. Study Design: Clinical capsule report. Setting: Tertiary academic referral center. Results: ECOG measurements were performed during cochlear implant surgery in an adult patient with significant residual acoustic hearing. The 500, 1000, and 2000 Hz CM tracings from the most apical electrode showed an amplitude peak at three different instances during the early phase of cochlear implant electrode insertion. These results are consistent with the tonotopic organization of the cochlea. During final electrode placement a slight advancement of the electrode array resulted in a correlated decrease in 250, 500, and/or 1000 Hz CM amplitude. The electrode array was retracted and repositioned which resulted in a recovery of CM amplitude. Intraoperative CM thresholds revealed a correlation of r = 0.87 with preoperative audiometric thresholds. Conclusion: We present a report on simultaneous multi-frequency ECOG monitoring during cochlear implant surgery. Multi-frequency ECOG can be used to differentiate between electrode trauma and the advancement of the apical electrode beyond the CM source in the cochlea.
Pediatric hodgkin lymphoma: disparities in survival by race
Khullar, Karishma , Rivera‐Núñez, Zorimar , Drachtman, Richard A. , Cole, Peter D. , Parikh, Rahul R. , Parikh, Rahul R , Jhawar, Sachin R. , Hoppe, Bradford S.

Mayo Clinic

Leukemia & Lymphoma | October 23, 2019 | Volume: 61 | Issue: 3 | Pages: 546-556

10.1080/10428194.2019.1680841 | PMID 31640446 Get It

The Impact of Urban Zen Integrative Therapy on Symptoms and Health-Related Quality of Life for Patients with Pulmonary Hypertension
Visger, Tania Von , Klatt, Maryanna , Dabbs, Annette DeVito , Tan, Alai , Happ, Mary Beth , Thrane, Susan E. , Chlan, Linda L.

Mayo Clinic

Journal of Palliative Medicine | October 23, 2019 | Volume: 23 | Issue: 5 | Pages: 703-711

10.1089/jpm.2019.0359 | PMID 31644380 Get It

Background: Patients with pulmonary hypertension (PH) experience distressing symptoms that can undermine quality of life (QoL) and treatment adherence. Complementary health approaches are known to help manage symptoms of chronic conditions and may have therapeutic benefits in PH. Objective: To explore the impact of Urban Zen Integrative Therapy (UZIT) on PH-related symptoms. Design: A within-subjects, pre-/post-intervention, repeated-measures design. Subjects/Setting: Community-dwelling adults with PH received weekly UZIT sessions in an outpatient setting. Measurements: Participants ( n = 14) rated symptoms before and after each session and before and after the six-week UZIT program. Mixed-effects modeling with repeated measures was used to estimate differences in mean symptom scores before and after individual sessions. Cohen's d effect sizes were used to evaluate the impact of the UZIT program on symptoms. Results: Mean scores for pain ( F (1, 105) = 19.99, p < 0.001), anxiety ( F (1, 96) = 24.64, p < 0.001), fatigue ( F (1, 120) = 15.68, p < 0.001), and dyspnea ( F (1, 68) = 16.69, p < 0.001) were significantly reduced after UZIT sessions. Effects were moderate to large for symptom severity ( d = 0.59–1.32) and moderate for symptom burden ( d = 0.56) and fatigue ( d = 0.62), and small for QoL ( d = 0.33) after the six-week UZIT program. Conclusions: Individualized UZIT sessions were associated with reductions in symptom severity for pain, anxiety, fatigue, and dyspnea. The six-week UZIT program was associated with improvements in symptom burden, activity limitation, and QoL. ClinicalTrial.gov no.: NCT03194438
Metabolite-mediated modelling of microbial community dynamics captures emergent behaviour more effectively than species–species modelling
Brunner, James D. , Chia, Nicholas

Mayo Clinic

Journal of The Royal Society Interface | October 23, 2019 | Volume: 16 | Issue: 159 | Pages: 20190423

10.1098/rsif.2019.0423 | PMID 31640497 Get It

Personalized models of the gut microbiome are valuable for disease prevention and treatment. For this, one requires a mathematical model that predicts microbial community composition and the emergent behaviour of microbial communities. We seek a modelling strategy that can capture emergent behaviour when built from sets of universal individual interactions. Our investigation reveals that species–metabolite interaction (SMI) modelling is better able to capture emergent behaviour in community composition dynamics than direct species–species modelling. Using publicly available data, we examine the ability of species–species models and species–metabolite models to predict trio growth experiments from the outcomes of pair growth experiments. We compare quadratic species–species interaction models and quadratic SMI models and conclude that only species–metabolite models have the necessary complexity to explain a wide variety of interdependent growth outcomes. We also show that general species–species interaction models cannot match the patterns observed in community growth dynamics, whereas species–metabolite models can. We conclude that species–metabolite modelling will be important in the development of accurate, clinically useful models of microbial communities.
Western Aphasia Battery–Revised Profiles in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech
Botha, Hugo , Josephs, Keith A. , Whitwell, Jennifer L. , Strand, Edythe A. , Botha, Hugo , Clark, Heather M. , Utianski, Rene L. , Duffy, Joseph R.

Mayo Clinic

American Journal of Speech-Language Pathology | October 23, 2019 | Volume: 29 | Issue: 1S | Pages: 498-510

10.1044/2019_ajslp-cac48-18-0217 | PMID 31639312 Get It

Purpose The primary aim was to examine the utility of the Western Aphasia Battery–Revised (WAB-R; Kertesz, 2007 ) for classifying variants of primary progressive aphasia (PPA). Traditional WAB-R metrics of Aphasia Quotient (AQ), subtest scores, WAB-R classification, and several novel metrics were examined. A secondary aim was to examine these same WAB-R metrics in individuals with primary progressive apraxia of speech (PPAOS). Method A retrospective analysis of WAB-R records from 169 participants enrolled in a study of neurodegenerative speech and language disorders was conducted. PPA/PPAOS classification was determined by consensus review of speech, language, and cognitive profiles. Scores on each of the WAB-R subtests were obtained to derive AQ, WAB-R aphasia profile, and 3 ratios reflecting relative performance on subtests. Results Mean AQ was significantly higher in the PPAOS group compared to all PPA variants except primary fluent aphasia. AQ above the normal cutoff was observed for 20% of participants with PPA. Significant main effects of group were noted for each of the subtests. Follow-up comparisons most frequently discriminated PPAOS, primary agrammatic aphasia (PAA), and logopenic progressive aphasia. Primary fluent aphasia and semantic dementia (SD) subtest scores were less distinctive, with the exception of Naming for SD, which was significantly lower than for PAA and PPAOS. When the WAB-R AQ detected aphasia, a classification of anomic aphasia was most frequently observed; this pattern held true for each of the PPA variants. The mean Information Content:Naming ratio was highest for SD, and the mean Comprehension:Fluency ratio was highest for PAA. Conclusions In the current study, AQ underestimated the presence of PPA and WAB-R classification did not distinguish among PPA classification determined by consensus. Performance on individual subtests and relative performance across subtests demonstrated inconsistent alignment with PPA classification. We conclude the WAB-R in isolation is inadequate to detect or characterize PPA. We instead suggest utilizing the WAB-R as 1 component of a comprehensive language and motor speech assessment when PPA is suspected.
Mutual Understanding: A Reflection on Gross Anatomy
Bolen, Erin E., Bolen, Erin E.

Mayo Clinic

Academic Medicine | October 23, 2019 | Volume: 94 | Issue: 8 | Pages: 1093-1093

10.1097/acm.0000000000002774 | PMID 31361640 Get It

Association of Apolipoprotein E ɛ4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults
Castillo, Anna , Graff‐Radford, Jonathan , Lowe, Val J. , Petersen, Ronald C. , Jack, Clifford R. , Vemuri, Prashanthi , Castillo, Anna M, Jack, Clifford R , Vemuri, Prashanthi , Castillo, Anna M , Ramanan, Vijay K. , Knopman, David S. , Mielke, Michelle M.

Mayo Clinic

JAMA Network Open | October 23, 2019 | Volume: 2 | Issue: 10 | Pages: e1913909

10.1001/jamanetworkopen.2019.13909 | PMID 31642932 Get It

Strengthening the Evidence for Cardiac Rehabilitation Benefits
Thomas, Randal J. , Brewer, LaPrincess C.

Mayo Clinic

JAMA Cardiology | October 23, 2019 | Volume: 4 | Issue: 12 | Pages: 1259

10.1001/jamacardio.2019.4077 | PMID 31642865 Get It

Design and reporting considerations for genetic screening tests
Hagenkord, Jill , Funke, Birgit , Hegde, Madhuri , Ferber, Matthew J. , Lebo, Matthew S. , Buchanan, Adam H. , Bick, David , Qian, Emily , Jacobs, Kevin B. , Lebo, Matthew

Mayo Clinic

No container title available | October 23, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7287/peerj.preprints.27922v4 Get It

Testing asymptomatic individuals for unsuspected conditions is not new to the medical and public health communities and protocols to develop screening tests are well-established. However, the application of screening principles to inherited diseases presents unique challenges. Unlike most screening tests, the natural history and disease prevalence of most rare inherited diseases in an unselected population are unknown. It is difficult or impossible to obtain a “truth set” cohort for clinical validation studies. As a result, it is not possible to accurately calculate clinical positive and negative predictive values for “likely pathogenic” genetic variants, which are commonly returned in genetic screening assays. In addition, many of the genetic conditions included in screening panels do not have clinical confirmatory tests. All of these elements are typically required to justify the development of a screening test, according to the World Health Organization screening principles. Nevertheless, as the cost of DNA sequencing continues to fall, more individuals are opting to undergo genomic testing in the absence of a clinical indication. Despite the challenges, reasonable estimates can be deduced and used to inform test design strategies. Here, we review test design principles and apply them to genetic screening.